bluebird bio Inc expected to post a loss of 36 cents a share - Earnings Preview

bluebird bio

12/11/2024 13:55

* bluebird bio Inc  BLUE.OQ   BLUE.O  is expected to show a
rise
in quarterly revenue when it reports  results on November 14 for
the period ending September 30 2024
    * The Somerville Massachusetts-based  company is expected to
report a 45.6% increase in revenue to $18.049 million from
$12.39 million a year ago, according to the mean estimate from 9
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for bluebird bio Inc is for
a loss
of 36 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 6
"hold" and 2 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for bluebird
bio Inc
is $2.50​, above​ its last closing price of $0.41. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.50       -0.42      -0.42     Met     -0.8
 Mar. 31 2024  -0.44       -0.44      -0.36     Beat    18.3
 Dec. 31 2023  -0.65       -0.66      -0.78     Missed  -17.8​
 Jan. 1 0001   -0.67       -0.67      -0.66     Beat    2.2
 ​​Jun.        -0.72       -0.72      -0.67     Beat    6.4
 30 2023                                                
 Mar. 31 2023  -0.27       -0.37      0.21      Beat    156.8​
 Dec. 31 2022  -0.37       -0.44      -0.81     Missed  -85.8
 Jan. 1 0001   -1.12       -1.12      -0.94     Beat    15.8
 This summary was machine generated November 12 at 13:54 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)